News, Resources, & Updates

US FDA Establishment Inspections: Outcomes for Labelers for Homeopathic Drugs

By Mark Land, AAHP President, June 2016 Abstract Labelers of homeopathic drugs are a subset of drug manufacturing establishments located within the United States and...

Understanding OTC Monograph Reform: Where Do We Stand Now?

By J.P. Borneman, Ph.D. and Alvin J. Lorman, J.D. The FDA’s Over-the-Counter Drug Review (OTC Review) has always been important to homeopathy, despite the fact...

Adulterants in Your Botanical Source Materials – How Do You Know?

By Eric L. Foxman, R.Ph Many commercially available botanical products have been adulterated prior to their introduction to the market. This is a problem that...

Homeopaths Without Borders Helps Haiti

Homeopaths Without Borders (HWB) has led 24 service trips to Haiti since 2010. With the help of volunteer homeopaths, individual donors, and homeopathic organizations and...

Webinar Review: FDA’s View on Compliance

On May 24, 2016, the American Association of Homeopathic Pharmacists hosted the latest in its Compliance through Education webinar series. The webinar featured a presentation...

FDA Guidance for Industry – Request for Quality Metrics

By Mark Land, AAHP President FDA published its draft guidance, Request for Quality Metrics; Guidance for Industry1. Advancing the background on the initiative in general,...

Homeopathic Drug Labels: Rx or OTC?

By J.P. Borneman, Ph.D. and Alvin J. Lorman Homeopathic drugs, we proudly tell folks, really are drugs: the Federal Food, Drug, and Cosmetic Act has...

Do Your Dosage Forms Appeal to Consumers?

By Eric L. Foxman, R.Ph. Consumers make purchase decisions based on several factors such as packaging and perceived effectiveness. Research shows dosage forms also factor...

Labeling homeopathic medicines for self-care

The U.S. Food and Drug Administration’s (FDA) electronic database of drug products contains more than 7,000 listings for over-the-counter (OTC) homeopathic products. The AAHP estimates...